Clinical Trial Update: Investigation to Understand and Optimize Psilocybin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating psilocybin for depression is currently recruiting. The study aims to better understand and optimize its effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Charles Raison | Conditions: Depression | Phase 2 | Status: RECRUITING